The estimated Net Worth of Brian M Mcnamee is at least $40.1 Million dollars as of 26 April 2013. Brian Mcnamee owns over 20,000 units of AMGEN stock worth over $21,330,897 and over the last 21 years Brian sold AMGN stock worth over $18,757,818.
Brian has made over 7 trades of the AMGEN stock since 2011, according to the Form 4 filled with the SEC. Most recently Brian exercised 20,000 units of AMGN stock worth $1,088,800 on 26 April 2013.
The largest trade Brian's ever made was selling 138,902 units of AMGEN stock on 27 January 2012 worth over $9,539,789. On average, Brian trades about 3,466 units every 8 days since 2003. As of 26 April 2013 Brian still owns at least 64,643 units of AMGEN stock.
You can see the complete history of Brian Mcnamee stock trades at the bottom of the page.
Brian's mailing address filed with the SEC is , , , , .
Over the last 22 years, insiders at AMGEN have traded over $219,663,137 worth of AMGEN stock and bought 8,904 units worth $919,219 . The most active insiders traders include Robert Eckert, Kevin W Sharer, and Ellen Jamison Kullman. On average, AMGEN executives and independent directors trade stock every 35 days with the average trade being worth of $8,732,261. The most recent stock trade was executed by Nancy A. Grygiel on 3 May 2024, trading 2,117 units of AMGN stock currently worth $662,812.
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.
AMGEN executives and other stock owners filed with the SEC include: